Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024
-
Clínica Bienestar
Clínica Bienestar (Spanish for “Wellness Clinic”) was developed to provide comprehensive, integrated HIV primary care services to Spanish-speaking and bilingual people of Puerto Rican ancestry, with HIV who inject drugs. Clínica Bienestar is a multilevel, multipronged intervention combining evidence-based practices in behavioral health and HIV medical care with a transnational approach to care. Clínica Bienestar positively impacted retention in HIV medical care and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 05/07/2024
-
Positive Peers Mobile App
The Positive Peers app motivates youth and young adults with HIV to stay engaged in HIV care through self-management tools and virtual support. Although specific outcomes vary by age group, individuals who used the app were more likely to attend their medical appointments, receive labs, and reach viral suppression.Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
-
New York City HIV Care Coordination Program
The New York City HIV Care Coordination Program is a structural intervention that combines multiple strategies, including multidisciplinary care coordination, patient navigation, and personalized health education to address client medical and social needs. Multiple evaluations of the program consistently show improvements in viral suppression and engagement in care, especially for people with a new diagnosis of HIV or who are out of care.Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
-
Glossary of HIV and Opioid Use Disorder Service Systems Terms
Terms describing key concepts and components of the HIV and opioid use disorder (OUD) care and treatment systems.Resource updated 09/19/2023
-
Innovative HIV Care Strategies to Address HIV and STIs
This webinar features Addressing STIs: Ask. Test. Treat. Repeat., an intervention for people with HIV or those who are vulnerable to HIV acquisition.Resource updated 05/15/2024
-
Replicating Innovative HIV Care Strategies in the RWHAP
Webinar series featuring HIV care innovations developed under HRSA SPNS projects.Resource updated 04/02/2024
-
JumpstART
JumpstART launched in 2016 as part of New York State’s Ending the Epidemic initiative, changing the service delivery model of eight sexual health clinics to include an initial prescription of ART after an HIV diagnosis and prior to linkage to the community provider. Between November 2016 and September 2018, 60% of JumpstART clients received ART on the same day as diagnosis. JumpstART clients were also more likely to reach viral suppression within three months compared to non-JumpstART clients.Resource from the RWHAP Best Practices Compilation updated on 12/15/2023
-
Best Practices Highlight: New York City Medical Home Model
A New York City HIV medical home model has documented significant improvements in care re-engagement and viral suppression.Blog updated 08/23/2023
-
Addressing STIs: Ask, Test, Treat, Repeat.
The Addressing STIs: Ask, Test, Treat, Repeat. intervention seeks to address the rising rates of sexually transmitted infections (STIs) in the United States over the past several years.Resource updated 05/15/2024
-
A Guide to Support Individuals with HIV/Hepatitis C in Substance Use Service Settings
Guide on how to coordinate HIV/HCV treatment with substance use treatment and recovery.Resource updated 09/19/2023
-
Interrupting Stigma: A Conceptual Map Depicting Stigma Pathways & Intervening Strategies at the Intersection of HIV and Opioid Use Disorder
Tool for addressing stigma in relation to systems-level policies and practices that can improve individual level interventions.Resource updated 09/19/2023
-
Clinical Trial: New Gonorrhea Treatment Effective
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023 -
EHE HIV Implementation Science Awards Track HRSA Initiatives
New grant awards for the latest round of funding of research on HIV interventions under the Ending the HIV Epidemic Initiative have been announced.News Article updated on 04/12/2024 -
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
POP-UP
POP-UP provides low-barrier comprehensive HIV primary care, substance use services, mental health services, and case management to people who are homeless and unstably housed with the goal of retaining clients in care and improving viral suppression. Among POP-UP participants, 44% who were unstably housed and not virally suppressed at the start of the study were virally suppressed 12 months after enrollment.Resource from the RWHAP Best Practices Compilation updated on 05/24/2024
-
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023